A multibillion-dollar expansion in Johnston County appears to be imminent for one of the world’s largest pharmaceutical companies, and it could be North Carolina’s largest capital investment announcement of the year.
Novo Nordisk (NYSE: NVO), manufacturer of the in-demand weight loss and diabetes drugs Wegovy and Ozempic, has been issued more than a dozen building permits in Johnston County in recent months. This follows the Danish pharmaceutical company spending millions of dollars to acquire more than 175 acres near its local facility in Clayton throughout 2023.
While the company is tight-lipped about an expansion, a spokesperson said there will be a “public announcement” about Novo Nordisk’s plans in the near future.
Triangle Business Journal







